3//SEC Filing
PHOENIX BIOTECH SPONSOR, LLC 3
Accession 0000899243-21-039297
CIK 0001870404other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 6:56 PM ET
Size
7.2 KB
Accession
0000899243-21-039297
Insider Transaction Report
Form 3
PHOENIX BIOTECH SPONSOR, LLC
10% Owner
Holdings
Warrants
Exercise: $11.50→ Class A common stock (331,632 underlying)- 663,263
Class A common stock
Class B common stock
→ Class A common stock (4,679,125 underlying)
Footnotes (6)
- [F1]These shares underlie 663,263 units of the issuer that the reporting person irrevocably committed to purchase.
- [F2]The Class B shares will automatically convert into Class A shares at the time of the issuer's initial business combination on a one-for-one basis, subject to certain adjustments described in the issuer's charter documents and have no expiration date.
- [F3]The shares of Class B common stock include up to 592,875 shares that are subject to forfeiture in the event the underwriters of the issuer's initial public offering do not exercise in full their over-allotment option.
- [F4]The warrants will become exercisable at the later of 30 days after the consummation of the issuer's initial business combination or 12 months from the completion of the issuer's initial public offering.
- [F5]The warrants will expire five years after the consummation of the issuer's initial business combination or earlier upon redemption of all of the issuer's outstanding Class A common shares or the issuer's liquidation.
- [F6]These warrants underlie 663,263 units of the issuer that this entity irrevocably committed to purchase.
Documents
Issuer
PHOENIX BIOTECH ACQUISITION CORP.
CIK 0001870404
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001870407
Filing Metadata
- Form type
- 3
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 6:56 PM ET
- Size
- 7.2 KB